This is a study thread and the previous important thread is:
http://www.hotcopper.com.au/post_thread.asp?fid=1&tid=58902&sym=EPT#149290
Suggest you start reading that gen. 4 thread first before starting with this one.
++++++++++++++++++++++++++++++++++++
There are a number of key FDA sites and some are:
12.29 The FDA: US Food and Drug Administration
http://www.fda.gov/default.htm
12.29.1 Investigational New Drug (IND) Application Process:
http://www.fda.gov/cder/regulatory/applications/ind_page_1.htm
12.29.2 FAST TRACK, PRIORITY REVIEW AND ACCELERATED APPROVAL: http://www.accessdata.fda.gov/scripts/cder/onctools/Accel.cfm
12.29.3 Orphan Drug Designation.
http://www.fda.gov/orphan/designat/faq.htm
12.29.4 New FDA regulations to ensure supplement purity and quantity of ingredients:
http://www.ozestock.com.au/MessageView.asp?PostID=216092&Symbol=NRT
At the moment EPT is discussing IND items with the FDA: see item 12.29.1.
Gerry
- Forums
- ASX - By Stock
- CUV
- 5. data and comments. 5
5. data and comments. 5
-
- There are more pages in this discussion • 191 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CUV (ASX) to my watchlist
|
|||||
Last
$15.27 |
Change
0.010(0.07%) |
Mkt cap ! $764.0M |
Open | High | Low | Value | Volume |
$15.25 | $15.32 | $15.22 | $298.2K | 19.55K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 21 | $16.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.50 | 1550 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 21 | 16.180 |
7 | 787 | 16.040 |
2 | 323 | 16.030 |
3 | 757 | 15.750 |
3 | 775 | 15.720 |
Price($) | Vol. | No. |
---|---|---|
14.500 | 1550 | 8 |
14.510 | 51 | 2 |
14.530 | 183 | 1 |
14.550 | 203 | 3 |
14.670 | 1 | 1 |
Last trade - 15.59pm 03/07/2024 (20 minute delay) ? |
Featured News
CUV (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO & MD
Anthony Noble
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online